Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation

Author:

Zhu Andrew X.12,Macarulla Teresa3,Javle Milind M.4,Kelley R. Kate5,Lubner Sam J.6,Adeva Jorge7,Cleary James M.8,Catenacci Daniel V. T.9,Borad Mitesh J.10,Bridgewater John A.11,Harris William P.12,Murphy Adrian G.13,Oh Do-Youn14,Whisenant Jonathan R.15,Lowery Maeve A.116,Goyal Lipika1,Shroff Rachna T.17,El-Khoueiry Anthony B.18,Chamberlain Christina X.1920,Aguado-Fraile Elia1921,Choe Sung1920,Wu Bin1922,Liu Hua1920,Gliser Camelia1920,Pandya Shuchi S.1920,Valle Juan W.23,Abou-Alfa Ghassan K.2425

Affiliation:

1. Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston

2. Jiahui International Cancer Center, Jiahui Health, Shanghai, China

3. Hospital Universitario Vall d’Hebron, Barcelona, Spain

4. Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, Texas

5. Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco

6. Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison

7. Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain

8. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

9. Department of Medicine, University of Chicago Medical Center, Chicago, Illinois

10. Department of Hematology-Oncology, Mayo Clinic, Scottsdale, Arizona

11. Department of Medical Oncology, University College London Cancer Institute, London, United Kingdom

12. Department of Medicine, University of Washington, Seattle

13. Department of Oncology–Gastrointestinal Cancer, Johns Hopkins University, Baltimore, Maryland

14. Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea

15. Medical Oncology and Hematology, Utah Cancer Specialists, Salt Lake City

16. Trinity St James Cancer Institute, Trinity College Dublin, Dublin, Ireland

17. Department of Medicine, University of Arizona Cancer Center, Tucson

18. Department of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles

19. Agios Pharmaceuticals Inc, Cambridge, Massachusetts

20. Now with Servier Pharmaceuticals, LLC, Boston, Massachusetts

21. Repare Therapeutics, Cambridge, Massachusetts

22. Bristol Myers Squibb, Cambridge, Massachusetts

23. Division of Cancer Sciences, University of Manchester, Department of Medical Oncology, The Christie National Health Service Foundation Trust, Manchester, United Kingdom

24. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

25. Department of Medicine, Weill Medical College at Cornell University, New York, New York

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Reference39 articles.

1. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise.;Saha;Oncologist,2016

2. Cholangiocarcinoma 2020: the next horizon in mechanisms and management.;Banales;Nat Rev Gastroenterol Hepatol,2020

3. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.;Valle;N Engl J Med,2010

4. Chemotherapy for cholangiocarcinoma: an update.;Ramírez-Merino;World J Gastrointest Oncol,2013

5. ABC-06: a randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced/metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.;Lamarca;J Clin Oncol,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3